data_2n0o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n0o _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -84.57 -44.82 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.282 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 84.3 mt -59.19 -49.36 93.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 12.1 Cg_endo -64.07 -41.5 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.505 1.47 . . . . 0.0 111.211 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.83 -48.45 77.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.858 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -36.0 82.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -31.81 68.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.362 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -81.25 -47.86 6.27 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.52 -34.18 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.6 -47.22 87.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.2 mptp? -61.42 -30.11 70.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -76.84 -2.82 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.507 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.46 -43.58 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.945 0.403 . . . . 0.0 110.603 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 tt . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.824 -179.04 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 2.5 pt -91.78 -46.69 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.767 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 76.7 mt -73.71 -49.43 6.25 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.741 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 23.9 Cg_exo -63.12 -44.4 15.57 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.058 1.839 . . . . 0.0 112.707 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.61 -48.86 80.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.602 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.61 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.997 0.427 . . . . 0.0 110.406 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -53.3 35.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.352 0.596 . . . . 0.0 109.547 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -39.55 96.07 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -50.94 -44.95 60.47 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.47 -42.91 74.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.772 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -65.57 -23.78 66.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.738 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 41.7 t30 -81.04 -12.69 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.059 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -101.38 -27.83 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.54 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 C--N 1.325 -0.462 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.799 -179.734 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -78.53 -43.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 97.6 mt -64.97 -48.19 72.13 Favored Pre-proline 0 C--O 1.222 -0.352 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.944 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 51.5 Cg_exo -46.01 -46.6 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.13 1.887 . . . . 0.0 112.128 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.91 -44.54 74.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.484 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.01 73.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.777 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -62.85 -32.6 73.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -83.74 -50.47 4.41 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.04 22.37 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 tp -55.75 -46.06 77.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.002 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 15.0 mmtm -59.8 -26.38 65.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.055 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -80.8 -6.42 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.451 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.46 -32.95 8.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.788 0.328 . . . . 0.0 110.864 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.4 tt . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.844 -179.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.407 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.486 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -85.26 -45.26 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.395 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 14.1 mt -54.21 -49.24 91.36 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 27.4 Cg_exo -54.19 -46.31 34.49 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.71 1.607 . . . . 0.0 112.057 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -62.22 -35.2 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 8' ' ' LEU . . . -60.63 -41.19 94.39 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -38.23 90.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.534 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.25 -27.82 65.91 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.51 -46.56 88.48 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 tp -56.64 -41.82 77.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.615 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -58.94 -25.63 63.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -83.64 -7.47 59.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.51 -23.69 15.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.313 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 tp . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.201 -179.231 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.451 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -88.41 -48.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.802 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 80.1 mt -53.41 -44.66 98.0 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.66 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 20.4 Cg_exo -60.05 -37.59 83.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.975 1.784 . . . . 0.0 112.06 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.4 mt -62.74 -53.9 47.37 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.761 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -34.82 70.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.214 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.51 -47.09 80.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.936 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.9 -43.4 99.38 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.66 12.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.75 -44.99 90.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -26.09 66.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.51 -10.97 59.91 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.041 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.4 mt -93.96 -25.8 17.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 tt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.149 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.584 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -81.93 -50.44 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.856 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.585 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 68.4 mt -55.33 -50.32 87.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -59.25 -37.15 92.97 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.296 1.331 . . . . 0.0 111.101 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.59 -46.02 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.507 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.96 -38.15 75.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.7 -9.81 55.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.705 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.59 -43.8 4.45 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.58 -47.78 39.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.8 tp -50.95 -42.42 59.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.885 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -67.05 -19.13 65.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.81 0.338 . . . . 0.0 110.441 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -85.91 -21.27 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.524 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.3 mt -96.78 -31.9 12.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.815 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 C--N 1.322 -0.617 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -179.359 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.487 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -71.93 -43.35 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.293 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.558 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 49.5 mt -68.32 -51.18 25.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.358 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -60.36 -40.47 57.99 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.725 1.617 . . . . 0.0 111.614 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.05 -46.52 82.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.838 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.21 -40.07 95.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.369 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -36.91 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.347 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.97 -46.23 29.55 Favored Glycine 0 N--CA 1.453 -0.22 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.42 -43.58 34.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.6 tp -55.29 -44.75 75.98 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.179 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -26.04 65.36 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -84.83 -7.46 59.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 mt -104.87 -14.2 15.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.651 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 tt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 -179.6 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.441 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -83.93 -39.11 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.259 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 16.2 mt -77.17 -48.02 2.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.136 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 6.1 Cg_exo -67.24 -31.26 36.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.816 1.677 . . . . 0.0 113.885 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -66.01 -38.66 89.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.692 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.39 -58.8 5.43 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.98 79.91 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.18 66.47 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -53.03 -43.48 66.6 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.551 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -68.26 -17.28 64.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.639 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -85.02 -7.6 59.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.608 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 111.026 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 tt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.654 -179.446 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.497 0.189 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.479 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -66.42 -46.06 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.673 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 29.1 mt -77.0 -50.66 2.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.378 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 31.5 Cg_exo -56.06 -41.33 78.02 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.817 1.678 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.93 -44.19 91.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.731 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.21 77.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -35.57 74.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.337 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.92 -38.6 26.48 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -37.89 26.08 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -57.32 -48.12 79.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HA ' ' CG2' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.79 -28.59 67.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -71.89 -17.46 62.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.763 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tp -101.49 -27.25 13.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.77 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 16.4 tt . . . . . 0 C--N 1.322 -0.597 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.125 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -87.18 -42.36 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.205 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 79.1 mt -58.4 -48.68 96.52 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.004 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 14.3 Cg_endo -66.62 -29.16 44.08 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.838 1.692 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -54.01 39.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.96 66.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.652 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tp -59.26 -25.37 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.631 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -86.86 -44.93 5.59 Favored Glycine 0 CA--C 1.515 0.079 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.0 -41.43 25.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -56.38 -40.26 74.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.518 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -68.17 -19.3 64.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.93 -18.52 32.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mp -94.21 -19.86 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.455 -179.859 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.552 HG13 ' H ' ' A' ' 2' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.552 ' H ' HG13 ' A' ' 1' ' ' ILE . 10.6 m-85 -46.91 -35.7 6.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.004 0.43 . . . . 0.0 111.524 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -73.05 -1.25 55.9 Favored Glycine 0 C--O 1.228 -0.242 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -118.7 -26.49 6.1 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -84.57 -44.82 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.282 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 84.3 mt -59.19 -49.36 93.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 12.1 Cg_endo -64.07 -41.5 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.505 1.47 . . . . 0.0 111.211 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.83 -48.45 77.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.858 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -36.0 82.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.8 -31.81 68.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.362 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -81.25 -47.86 6.27 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.52 -34.18 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.6 -47.22 87.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.2 mptp? -61.42 -30.11 70.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.403 ' OD1' ' NZ ' ' A' ' 18' ' ' LYS . 30.0 t-20 -76.84 -2.82 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.507 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.46 -43.58 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.945 0.403 . . . . 0.0 110.603 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.521 ' CG2' ' H ' ' A' ' 18' ' ' LYS . 5.1 tt -82.49 -61.19 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.824 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.521 ' H ' ' CG2' ' A' ' 17' ' ' ILE . 0.7 OUTLIER 63.52 -55.84 0.2 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.208 -178.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . 0.44 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.298 -1.673 0 O-C-N 119.759 -1.838 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.56 HD12 ' N ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.56 ' N ' HD12 ' A' ' 1' ' ' ILE . 12.7 p90 -68.3 -9.7 49.55 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.433 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -72.19 0.1 41.63 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.53 -18.1 6.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 2.5 pt -91.78 -46.69 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.767 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 76.7 mt -73.71 -49.43 6.25 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.741 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 23.9 Cg_exo -63.12 -44.4 15.57 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.058 1.839 . . . . 0.0 112.707 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.61 -48.86 80.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.602 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.61 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.997 0.427 . . . . 0.0 110.406 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -53.3 35.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.352 0.596 . . . . 0.0 109.547 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -39.55 96.07 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -50.94 -44.95 60.47 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.47 -42.91 74.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.772 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -65.57 -23.78 66.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.738 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 41.7 t30 -81.04 -12.69 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.059 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -101.38 -27.83 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.54 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 19' ' ' NH2 . 16.3 tt -94.65 -46.05 13.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.799 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.76 -55.32 0.09 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.035 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . 0.457 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.301 -1.528 0 O-C-N 119.834 -1.791 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.56 HG23 ' H ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.56 ' H ' HG23 ' A' ' 1' ' ' ILE . 41.1 m-85 -45.73 -28.89 1.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.064 0.459 . . . . 0.0 111.63 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.06 -5.57 41.3 Favored Glycine 0 C--N 1.32 -0.324 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.95 -34.05 3.62 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -78.53 -43.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 97.6 mt -64.97 -48.19 72.13 Favored Pre-proline 0 C--O 1.222 -0.352 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.944 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 51.5 Cg_exo -46.01 -46.6 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.13 1.887 . . . . 0.0 112.128 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.91 -44.54 74.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.484 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.01 73.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.777 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -62.85 -32.6 73.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -83.74 -50.47 4.41 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.04 22.37 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 tp -55.75 -46.06 77.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.002 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 15.0 mmtm -59.8 -26.38 65.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.055 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 30.0 t-20 -80.8 -6.42 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.451 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.46 -32.95 8.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.788 0.328 . . . . 0.0 110.864 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.494 ' O ' ' N ' ' A' ' 19' ' ' NH2 . 7.4 tt -90.65 -43.74 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.844 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 15' ' ' ASN . 1.1 mptp? 62.77 -53.92 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.516 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . 0.494 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.298 -1.642 0 O-C-N 119.973 -1.704 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.556 HG13 ' N ' ' A' ' 2' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.556 ' N ' HG13 ' A' ' 1' ' ' ILE . 76.8 m-85 -48.41 -29.58 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.093 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -73.28 -5.51 66.92 Favored Glycine 0 N--CA 1.46 0.235 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -110.4 -27.86 8.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.486 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -85.26 -45.26 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.395 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 14.1 mt -54.21 -49.24 91.36 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 27.4 Cg_exo -54.19 -46.31 34.49 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.71 1.607 . . . . 0.0 112.057 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -62.22 -35.2 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 8' ' ' LEU . . . -60.63 -41.19 94.39 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -38.23 90.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.534 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.25 -27.82 65.91 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.51 -46.56 88.48 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 tp -56.64 -41.82 77.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.615 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -58.94 -25.63 63.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.555 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 17.4 t-20 -83.64 -7.47 59.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.51 -23.69 15.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.313 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 tp -101.74 -46.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.201 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER 57.27 -98.78 0.09 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.203 -179.392 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.537 0 O-C-N 120.083 -1.636 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 2' ' ' PHE . 8.3 tp . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.501 ' N ' HG13 ' A' ' 1' ' ' ILE . 70.9 m-85 -39.65 -37.6 0.53 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.185 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.72 -8.26 39.46 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -116.63 -26.39 7.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.012 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -88.41 -48.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.802 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 80.1 mt -53.41 -44.66 98.0 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.66 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 20.4 Cg_exo -60.05 -37.59 83.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.975 1.784 . . . . 0.0 112.06 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.4 mt -62.74 -53.9 47.37 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.761 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -34.82 70.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.214 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.51 -47.09 80.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.936 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.9 -43.4 99.38 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.66 12.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.75 -44.99 90.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -26.09 66.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 t-20 -75.51 -10.97 59.91 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.041 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.437 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 65.4 mt -93.96 -25.8 17.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 tt -93.82 -43.36 13.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.149 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 52.81 -130.73 2.2 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.5 0 O-C-N 119.943 -1.723 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.554 HG22 ' H ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.554 ' H ' HG22 ' A' ' 1' ' ' ILE . 8.1 m-85 -49.96 -34.66 21.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.505 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -72.81 3.67 26.25 Favored Glycine 0 C--N 1.323 -0.188 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -120.44 -29.96 4.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.584 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -81.93 -50.44 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.856 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.585 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 68.4 mt -55.33 -50.32 87.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -59.25 -37.15 92.97 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.296 1.331 . . . . 0.0 111.101 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.59 -46.02 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.507 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.96 -38.15 75.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.7 -9.81 55.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.705 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.59 -43.8 4.45 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.58 -47.78 39.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.8 tp -50.95 -42.42 59.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.885 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -67.05 -19.13 65.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.81 0.338 . . . . 0.0 110.441 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -85.91 -21.27 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.524 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.3 mt -96.78 -31.9 12.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.815 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.8 tt -95.59 -41.82 12.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.26 -127.1 0.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.867 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.466 0 O-C-N 119.596 -1.94 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.563 HG13 ' H ' ' A' ' 2' ' ' PHE . 5.1 tp . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' H ' HG13 ' A' ' 1' ' ' ILE . 0.1 OUTLIER -48.18 -25.19 1.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.243 0.544 . . . . 0.0 110.558 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.479 ' H ' ' CG2' ' A' ' 1' ' ' ILE . . . -72.69 6.51 11.95 Favored Glycine 0 CA--C 1.518 0.223 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 2' ' ' PHE . . . -127.04 -38.24 2.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -71.93 -43.35 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.293 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.558 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 49.5 mt -68.32 -51.18 25.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.358 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -60.36 -40.47 57.99 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.725 1.617 . . . . 0.0 111.614 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.05 -46.52 82.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.838 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.21 -40.07 95.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.369 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -36.91 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.347 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.97 -46.23 29.55 Favored Glycine 0 N--CA 1.453 -0.22 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.42 -43.58 34.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.6 tp -55.29 -44.75 75.98 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.179 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -26.04 65.36 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.775 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -84.83 -7.46 59.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 mt -104.87 -14.2 15.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.651 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.402 ' C ' ' HG2' ' A' ' 18' ' ' LYS . 5.9 tt -102.75 -43.46 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' HG2' ' C ' ' A' ' 17' ' ' ILE . 4.7 mmtm 65.88 -51.68 0.39 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.426 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.552 0 O-C-N 120.172 -1.58 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.596 ' CG1' ' H ' ' A' ' 2' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.596 ' H ' ' CG1' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -52.17 -20.25 2.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.791 0.329 . . . . 0.0 110.845 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.497 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -72.89 3.0 30.33 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.21 -30.99 3.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -83.93 -39.11 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.259 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.527 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 16.2 mt -77.17 -48.02 2.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.136 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 6.1 Cg_exo -67.24 -31.26 36.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.816 1.677 . . . . 0.0 113.885 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -66.01 -38.66 89.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.692 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.39 -58.8 5.43 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.98 79.91 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.18 66.47 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -53.03 -43.48 66.6 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.551 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -68.26 -17.28 64.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.639 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -85.02 -7.6 59.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.608 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 111.026 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.496 ' C ' ' HD3' ' A' ' 18' ' ' LYS . 15.4 tt -88.04 -45.63 15.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.654 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 66.89 -150.63 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.808 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.59 0 O-C-N 119.902 -1.748 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.573 HG13 ' N ' ' A' ' 2' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.573 ' N ' HG13 ' A' ' 1' ' ' ILE . 0.1 OUTLIER -65.36 -2.92 3.53 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.229 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.04 1.07 81.41 Favored Glycine 0 C--N 1.322 -0.228 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.61 -35.21 0.74 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.067 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.496 HG12 ' HA ' ' A' ' 2' ' ' PHE . 1.1 pt -66.42 -46.06 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.673 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 29.1 mt -77.0 -50.66 2.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.378 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 31.5 Cg_exo -56.06 -41.33 78.02 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.817 1.678 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.93 -44.19 91.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.731 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.21 77.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -35.57 74.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.337 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.92 -38.6 26.48 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -37.89 26.08 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -57.32 -48.12 79.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HA ' ' CG2' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.79 -28.59 67.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -71.89 -17.46 62.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.763 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 5.5 tp -101.49 -27.25 13.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.77 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 16.4 tt -84.92 -44.15 17.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.125 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.441 ' HD2' ' C ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER 50.33 35.71 11.36 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.756 0.312 . . . . 0.0 110.424 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.566 0 O-C-N 119.885 -1.759 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.564 ' CG1' ' H ' ' A' ' 2' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.564 ' H ' ' CG1' ' A' ' 1' ' ' ILE . 1.0 OUTLIER -45.66 -30.5 1.56 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.085 0.469 . . . . 0.0 111.322 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.53 -7.74 48.37 Favored Glycine 0 N--CA 1.459 0.215 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.61 -29.8 7.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -87.18 -42.36 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.205 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 79.1 mt -58.4 -48.68 96.52 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.004 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 14.3 Cg_endo -66.62 -29.16 44.08 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.838 1.692 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -54.01 39.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.96 66.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.652 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tp -59.26 -25.37 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.631 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -86.86 -44.93 5.59 Favored Glycine 0 CA--C 1.515 0.079 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.0 -41.43 25.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -56.38 -40.26 74.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.518 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -68.17 -19.3 64.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.93 -18.52 32.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.446 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 4.3 mp -94.21 -19.86 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.895 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.497 ' C ' ' HD3' ' A' ' 18' ' ' LYS . 4.4 tt -85.42 -48.84 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.455 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' HD3' ' C ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 65.18 -52.75 0.34 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.47 179.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.58 0 O-C-N 120.174 -1.579 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -84.57 -44.82 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.282 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.562 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 84.3 mt -59.19 -49.36 93.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 12.1 Cg_endo -64.07 -41.5 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.505 1.47 . . . . 0.0 111.211 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.83 -48.45 77.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.858 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -36.0 82.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -58.8 -31.81 68.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.362 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -81.25 -47.86 6.27 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.52 -34.18 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 17' ' ' ILE . 19.6 tp -60.6 -47.22 87.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.2 mptp? -61.42 -30.11 70.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -76.84 -2.82 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.507 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.46 -43.58 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.945 0.403 . . . . 0.0 110.603 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 13' ' ' LEU . 5.1 tt . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.824 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 2.5 pt -91.78 -46.69 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.767 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 76.7 mt -73.71 -49.43 6.25 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.741 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 23.9 Cg_exo -63.12 -44.4 15.57 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.058 1.839 . . . . 0.0 112.707 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 8' ' ' LEU . 4.3 mm? -59.61 -48.86 80.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.602 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.61 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.997 0.427 . . . . 0.0 110.406 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -53.3 35.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.352 0.596 . . . . 0.0 109.547 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -39.55 96.07 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -50.94 -44.95 60.47 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.47 -42.91 74.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.772 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -65.57 -23.78 66.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.738 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 41.7 t30 -81.04 -12.69 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.059 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -101.38 -27.83 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.54 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 14' ' ' LYS . 16.3 tt . . . . . 0 C--N 1.325 -0.462 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.799 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -78.53 -43.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 97.6 mt -64.97 -48.19 72.13 Favored Pre-proline 0 C--O 1.222 -0.352 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.944 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 51.5 Cg_exo -46.01 -46.6 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.13 1.887 . . . . 0.0 112.128 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.91 -44.54 74.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.484 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.01 73.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.777 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -62.85 -32.6 73.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -83.74 -50.47 4.41 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.04 22.37 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 tp -55.75 -46.06 77.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.002 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 15.0 mmtm -59.8 -26.38 65.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.055 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -80.8 -6.42 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.451 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.46 -32.95 8.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.788 0.328 . . . . 0.0 110.864 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.4 tt . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.844 -179.732 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.408 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.587 ' HA ' HD23 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -85.26 -45.26 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.395 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 14.1 mt -54.21 -49.24 91.36 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 27.4 Cg_exo -54.19 -46.31 34.49 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.71 1.607 . . . . 0.0 112.057 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.612 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -62.22 -35.2 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.47 ' N ' ' HG ' ' A' ' 8' ' ' LEU . . . -60.63 -41.19 94.39 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -62.92 -38.23 90.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.534 178.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.25 -27.82 65.91 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.51 -46.56 88.48 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 tp -56.64 -41.82 77.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.615 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -58.94 -25.63 63.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -83.64 -7.47 59.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 16' ' ' LEU . 2.1 mm? -97.51 -23.69 15.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.313 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 tp . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.201 -179.231 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.461 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -88.41 -48.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.802 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 80.1 mt -53.41 -44.66 98.0 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.66 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 20.4 Cg_exo -60.05 -37.59 83.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.975 1.784 . . . . 0.0 112.06 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 8' ' ' LEU . 76.4 mt -62.74 -53.9 47.37 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.761 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -34.82 70.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.214 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.51 -47.09 80.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.936 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.9 -43.4 99.38 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.66 12.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.75 -44.99 90.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -26.09 66.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.51 -10.97 59.91 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.041 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.4 mt -93.96 -25.8 17.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 tt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.149 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.584 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -81.93 -50.44 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.856 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 68.4 mt -55.33 -50.32 87.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -59.25 -37.15 92.97 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.296 1.331 . . . . 0.0 111.101 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.59 -46.02 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.507 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.96 -38.15 75.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -69.7 -9.81 55.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.705 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.59 -43.8 4.45 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.58 -47.78 39.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.616 ' O ' HG22 ' A' ' 17' ' ' ILE . 26.8 tp -50.95 -42.42 59.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.885 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -67.05 -19.13 65.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.81 0.338 . . . . 0.0 110.441 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -85.91 -21.27 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.524 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.3 mt -96.78 -31.9 12.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.815 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 13' ' ' LEU . 17.8 tt . . . . . 0 C--N 1.322 -0.617 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.487 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -71.93 -43.35 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.293 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.573 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 49.5 mt -68.32 -51.18 25.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.358 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -60.36 -40.47 57.99 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.725 1.617 . . . . 0.0 111.614 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.05 -46.52 82.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.838 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.21 -40.07 95.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.369 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -36.91 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.347 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.97 -46.23 29.55 Favored Glycine 0 N--CA 1.453 -0.22 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.42 -43.58 34.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.6 tp -55.29 -44.75 75.98 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.179 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -59.76 -26.04 65.36 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.775 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -84.83 -7.46 59.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 mt -104.87 -14.2 15.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.651 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 14' ' ' LYS . 5.9 tt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.448 HG12 ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -83.93 -39.11 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.259 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 16.2 mt -77.17 -48.02 2.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.136 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 6.1 Cg_exo -67.24 -31.26 36.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.816 1.677 . . . . 0.0 113.885 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -66.01 -38.66 89.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.692 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.39 -58.8 5.43 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.98 79.91 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -60.07 -52.18 66.47 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 17' ' ' ILE . 50.2 tp -53.03 -43.48 66.6 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.551 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -68.26 -17.28 64.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.639 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -85.02 -7.6 59.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.608 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 111.026 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 13' ' ' LEU . 15.4 tt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.654 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.497 0.189 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.479 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -66.42 -46.06 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.673 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 29.1 mt -77.0 -50.66 2.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.378 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 31.5 Cg_exo -56.06 -41.33 78.02 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.817 1.678 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.93 -44.19 91.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.731 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.21 77.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -35.57 74.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.337 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.92 -38.6 26.48 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -37.89 26.08 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -57.32 -48.12 79.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.79 -28.59 67.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -71.89 -17.46 62.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.763 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tp -101.49 -27.25 13.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.77 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 14' ' ' LYS . 16.4 tt . . . . . 0 C--N 1.322 -0.597 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.125 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -87.18 -42.36 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.205 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.559 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 79.1 mt -58.4 -48.68 96.52 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.004 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 14.3 Cg_endo -66.62 -29.16 44.08 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.838 1.692 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -54.01 39.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.96 66.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.652 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.464 ' O ' ' NZ ' ' A' ' 14' ' ' LYS . 3.0 tp -59.26 -25.37 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.631 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -86.86 -44.93 5.59 Favored Glycine 0 CA--C 1.515 0.079 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.0 -41.43 25.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -56.38 -40.26 74.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.518 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.571 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -68.17 -19.3 64.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.93 -18.52 32.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mp -94.21 -19.86 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.455 -179.859 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.695 ' N ' HG23 ' A' ' 1' ' ' ILE . 10.6 m-85 -46.91 -35.7 6.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.004 0.43 . . . . 0.0 111.524 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -73.05 -1.25 55.9 Favored Glycine 0 C--O 1.228 -0.242 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -118.7 -26.49 6.1 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 1' ' ' ILE . 1.1 pt -84.57 -44.82 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.282 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.562 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 84.3 mt -59.19 -49.36 93.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 12.1 Cg_endo -64.07 -41.5 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.505 1.47 . . . . 0.0 111.211 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.83 -48.45 77.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.858 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -36.0 82.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -58.8 -31.81 68.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.362 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -81.25 -47.86 6.27 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.52 -34.18 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 17' ' ' ILE . 19.6 tp -60.6 -47.22 87.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.2 mptp? -61.42 -30.11 70.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.476 ' OD1' ' NZ ' ' A' ' 18' ' ' LYS . 30.0 t-20 -76.84 -2.82 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.507 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.46 -43.58 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.945 0.403 . . . . 0.0 110.603 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.759 HG23 ' H ' ' A' ' 18' ' ' LYS . 5.1 tt -82.49 -61.19 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.824 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.759 ' H ' HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER 63.52 -55.84 0.2 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.208 -178.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.298 -1.673 0 O-C-N 119.759 -1.838 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.72 HD13 ' N ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.72 ' N ' HD13 ' A' ' 1' ' ' ILE . 12.7 p90 -68.3 -9.7 49.55 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.433 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -72.19 0.1 41.63 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.53 -18.1 6.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 2.5 pt -91.78 -46.69 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.767 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 76.7 mt -73.71 -49.43 6.25 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.741 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 23.9 Cg_exo -63.12 -44.4 15.57 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.058 1.839 . . . . 0.0 112.707 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 8' ' ' LEU . 4.3 mm? -59.61 -48.86 80.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.602 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.61 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.997 0.427 . . . . 0.0 110.406 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -53.3 35.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.352 0.596 . . . . 0.0 109.547 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -39.55 96.07 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -50.94 -44.95 60.47 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.47 -42.91 74.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.772 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -65.57 -23.78 66.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.738 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 41.7 t30 -81.04 -12.69 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.059 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -101.38 -27.83 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.54 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 19' ' ' NH2 . 16.3 tt -94.65 -46.05 13.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.799 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER 60.76 -55.32 0.09 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.035 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . 0.53 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.301 -1.528 0 O-C-N 119.834 -1.791 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.561 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.557 ' H ' HG23 ' A' ' 1' ' ' ILE . 41.1 m-85 -45.73 -28.89 1.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.064 0.459 . . . . 0.0 111.63 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.06 -5.57 41.3 Favored Glycine 0 C--N 1.32 -0.324 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.95 -34.05 3.62 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -78.53 -43.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 97.6 mt -64.97 -48.19 72.13 Favored Pre-proline 0 C--O 1.222 -0.352 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.944 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 51.5 Cg_exo -46.01 -46.6 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.13 1.887 . . . . 0.0 112.128 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.91 -44.54 74.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.484 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.01 73.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.777 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -62.85 -32.6 73.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -83.74 -50.47 4.41 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.04 22.37 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 tp -55.75 -46.06 77.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.002 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 15.0 mmtm -59.8 -26.38 65.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.055 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.508 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 30.0 t-20 -80.8 -6.42 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.451 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.46 -32.95 8.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.788 0.328 . . . . 0.0 110.864 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 19' ' ' NH2 . 7.4 tt -90.65 -43.74 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.844 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 15' ' ' ASN . 1.1 mptp? 62.77 -53.92 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.516 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . 0.52 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.298 -1.642 0 O-C-N 119.973 -1.704 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.789 HG23 ' H ' ' A' ' 2' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.789 ' H ' HG23 ' A' ' 1' ' ' ILE . 76.8 m-85 -48.41 -29.58 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.093 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -73.28 -5.51 66.92 Favored Glycine 0 N--CA 1.46 0.235 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.408 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . -110.4 -27.86 8.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.587 ' HA ' HD23 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -85.26 -45.26 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.395 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 14.1 mt -54.21 -49.24 91.36 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 27.4 Cg_exo -54.19 -46.31 34.49 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.71 1.607 . . . . 0.0 112.057 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.612 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -62.22 -35.2 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.47 ' N ' ' HG ' ' A' ' 8' ' ' LEU . . . -60.63 -41.19 94.39 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -62.92 -38.23 90.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.534 178.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.25 -27.82 65.91 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.51 -46.56 88.48 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 tp -56.64 -41.82 77.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.615 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -58.94 -25.63 63.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.572 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 17.4 t-20 -83.64 -7.47 59.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 16' ' ' LEU . 2.1 mm? -97.51 -23.69 15.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.313 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 18' ' ' LYS . 4.2 tp -101.74 -46.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.201 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.572 ' NZ ' ' O ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER 57.27 -98.78 0.09 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.203 -179.392 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.537 0 O-C-N 120.083 -1.636 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 5' ' ' ILE . 8.3 tp . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.498 ' N ' HG13 ' A' ' 1' ' ' ILE . 70.9 m-85 -39.65 -37.6 0.53 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.185 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.72 -8.26 39.46 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.461 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . -116.63 -26.39 7.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.012 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 1' ' ' ILE . 0.1 OUTLIER -88.41 -48.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.802 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 80.1 mt -53.41 -44.66 98.0 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.66 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 20.4 Cg_exo -60.05 -37.59 83.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.975 1.784 . . . . 0.0 112.06 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 8' ' ' LEU . 76.4 mt -62.74 -53.9 47.37 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.761 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -34.82 70.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.214 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.51 -47.09 80.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.936 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.9 -43.4 99.38 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.66 12.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.75 -44.99 90.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -26.09 66.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.568 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 t-20 -75.51 -10.97 59.91 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.041 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.469 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 65.4 mt -93.96 -25.8 17.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 18' ' ' LYS . 8.9 tt -93.82 -43.36 13.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.149 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' NZ ' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 52.81 -130.73 2.2 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.5 0 O-C-N 119.943 -1.723 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.673 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.584 ' H ' HG23 ' A' ' 1' ' ' ILE . 8.1 m-85 -49.96 -34.66 21.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.505 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -72.81 3.67 26.25 Favored Glycine 0 C--N 1.323 -0.188 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -120.44 -29.96 4.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 1' ' ' ILE . 1.1 pt -81.93 -50.44 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.856 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 68.4 mt -55.33 -50.32 87.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -59.25 -37.15 92.97 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.296 1.331 . . . . 0.0 111.101 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.59 -46.02 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.507 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.96 -38.15 75.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -69.7 -9.81 55.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.705 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.59 -43.8 4.45 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.58 -47.78 39.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.616 ' O ' HG22 ' A' ' 17' ' ' ILE . 26.8 tp -50.95 -42.42 59.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.885 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -67.05 -19.13 65.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.81 0.338 . . . . 0.0 110.441 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -85.91 -21.27 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.524 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.3 mt -96.78 -31.9 12.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.815 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 13' ' ' LEU . 17.8 tt -95.59 -41.82 12.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.2 OUTLIER 63.26 -127.1 0.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.867 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.466 0 O-C-N 119.596 -1.94 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.727 HG23 ' H ' ' A' ' 3' ' ' GLY . 5.1 tp . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.564 ' H ' HG13 ' A' ' 1' ' ' ILE . 0.1 OUTLIER -48.18 -25.19 1.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.243 0.544 . . . . 0.0 110.558 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.727 ' H ' HG23 ' A' ' 1' ' ' ILE . . . -72.69 6.51 11.95 Favored Glycine 0 CA--C 1.518 0.223 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -127.04 -38.24 2.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -71.93 -43.35 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.293 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.573 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 49.5 mt -68.32 -51.18 25.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.358 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -60.36 -40.47 57.99 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.725 1.617 . . . . 0.0 111.614 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.05 -46.52 82.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.838 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.21 -40.07 95.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.369 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -36.91 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.347 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.97 -46.23 29.55 Favored Glycine 0 N--CA 1.453 -0.22 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.42 -43.58 34.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.6 tp -55.29 -44.75 75.98 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.179 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -59.76 -26.04 65.36 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.775 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -84.83 -7.46 59.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 mt -104.87 -14.2 15.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.651 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 18' ' ' LYS . 5.9 tt -102.75 -43.46 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' N ' HG23 ' A' ' 17' ' ' ILE . 4.7 mmtm 65.88 -51.68 0.39 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.426 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.552 0 O-C-N 120.172 -1.58 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.558 ' CG1' ' H ' ' A' ' 2' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.558 ' H ' ' CG1' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -52.17 -20.25 2.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.791 0.329 . . . . 0.0 110.845 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.529 ' H ' HG23 ' A' ' 1' ' ' ILE . . . -72.89 3.0 30.33 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.21 -30.99 3.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -83.93 -39.11 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.259 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 16.2 mt -77.17 -48.02 2.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.136 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 6.1 Cg_exo -67.24 -31.26 36.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.816 1.677 . . . . 0.0 113.885 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -66.01 -38.66 89.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.692 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.39 -58.8 5.43 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.98 79.91 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -60.07 -52.18 66.47 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 17' ' ' ILE . 50.2 tp -53.03 -43.48 66.6 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.551 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -68.26 -17.28 64.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.639 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -85.02 -7.6 59.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.608 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 111.026 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 18' ' ' LYS . 15.4 tt -88.04 -45.63 15.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.654 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 66.89 -150.63 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.808 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.59 0 O-C-N 119.902 -1.748 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.63 ' H ' HG23 ' A' ' 1' ' ' ILE . 0.1 OUTLIER -65.36 -2.92 3.53 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.229 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.04 1.07 81.41 Favored Glycine 0 C--N 1.322 -0.228 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.61 -35.21 0.74 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.067 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 1' ' ' ILE . 1.1 pt -66.42 -46.06 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.673 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 29.1 mt -77.0 -50.66 2.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.378 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 31.5 Cg_exo -56.06 -41.33 78.02 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.817 1.678 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.93 -44.19 91.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.731 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.21 77.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -35.57 74.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.337 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.92 -38.6 26.48 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -37.89 26.08 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -57.32 -48.12 79.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.79 -28.59 67.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 53.5 t30 -71.89 -17.46 62.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.763 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.467 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 5.5 tp -101.49 -27.25 13.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.77 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 14' ' ' LYS . 16.4 tt -84.92 -44.15 17.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.125 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.48 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER 50.33 35.71 11.36 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.756 0.312 . . . . 0.0 110.424 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.566 0 O-C-N 119.885 -1.759 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.61 HG23 ' H ' ' A' ' 3' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.535 ' H ' ' CG1' ' A' ' 1' ' ' ILE . 1.0 OUTLIER -45.66 -30.5 1.56 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.085 0.469 . . . . 0.0 111.322 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.61 ' H ' HG23 ' A' ' 1' ' ' ILE . . . -67.53 -7.74 48.37 Favored Glycine 0 N--CA 1.459 0.215 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.61 -29.8 7.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -87.18 -42.36 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.205 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.559 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 79.1 mt -58.4 -48.68 96.52 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.004 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 14.3 Cg_endo -66.62 -29.16 44.08 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.838 1.692 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -54.01 39.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.96 66.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.652 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' O ' ' NZ ' ' A' ' 14' ' ' LYS . 3.0 tp -59.26 -25.37 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.631 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -86.86 -44.93 5.59 Favored Glycine 0 CA--C 1.515 0.079 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.0 -41.43 25.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -56.38 -40.26 74.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.518 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -68.17 -19.3 64.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.93 -18.52 32.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' C ' ' HD3' ' A' ' 18' ' ' LYS . 4.3 mp -94.21 -19.86 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.895 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 18' ' ' LYS . 4.4 tt -85.42 -48.84 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.455 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER 65.18 -52.75 0.34 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.47 179.383 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' NH2 . . . . . 0.463 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.58 0 O-C-N 120.174 -1.579 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -84.57 -44.82 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.282 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.562 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 84.3 mt -59.19 -49.36 93.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 12.1 Cg_endo -64.07 -41.5 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.505 1.47 . . . . 0.0 111.211 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.83 -48.45 77.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.858 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -36.0 82.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.3 OUTLIER -58.8 -31.81 68.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.362 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -81.25 -47.86 6.27 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.52 -34.18 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 17' ' ' ILE . 19.6 tp -60.6 -47.22 87.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.2 mptp? -61.42 -30.11 70.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -76.84 -2.82 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.507 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.46 -43.58 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.945 0.403 . . . . 0.0 110.603 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 13' ' ' LEU . 5.1 tt . . . . . 0 C--N 1.322 -0.614 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.824 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 2.5 pt -91.78 -46.69 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.767 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 76.7 mt -73.71 -49.43 6.25 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.741 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 23.9 Cg_exo -63.12 -44.4 15.57 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.058 1.839 . . . . 0.0 112.707 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 8' ' ' LEU . 4.3 mm? -59.61 -48.86 80.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.602 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.61 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.997 0.427 . . . . 0.0 110.406 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -53.3 35.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.352 0.596 . . . . 0.0 109.547 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -39.55 96.07 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -50.94 -44.95 60.47 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.47 -42.91 74.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.772 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -65.57 -23.78 66.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.738 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 41.7 t30 -81.04 -12.69 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.059 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -101.38 -27.83 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.54 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 14' ' ' LYS . 16.3 tt . . . . . 0 C--N 1.325 -0.462 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.799 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -78.53 -43.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 97.6 mt -64.97 -48.19 72.13 Favored Pre-proline 0 C--O 1.222 -0.352 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.944 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 51.5 Cg_exo -46.01 -46.6 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.13 1.887 . . . . 0.0 112.128 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.91 -44.54 74.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.484 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.01 73.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.777 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -62.85 -32.6 73.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -83.74 -50.47 4.41 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.04 22.37 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 tp -55.75 -46.06 77.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.002 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 15.0 mmtm -59.8 -26.38 65.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.055 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -80.8 -6.42 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.451 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.46 -32.95 8.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.788 0.328 . . . . 0.0 110.864 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.4 tt . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.844 -179.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.408 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.587 ' HA ' HD23 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -85.26 -45.26 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.395 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 14.1 mt -54.21 -49.24 91.36 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 27.4 Cg_exo -54.19 -46.31 34.49 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.71 1.607 . . . . 0.0 112.057 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.612 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -62.22 -35.2 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.47 ' N ' ' HG ' ' A' ' 8' ' ' LEU . . . -60.63 -41.19 94.39 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -62.92 -38.23 90.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.534 178.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.25 -27.82 65.91 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.51 -46.56 88.48 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 tp -56.64 -41.82 77.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.615 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -58.94 -25.63 63.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -83.64 -7.47 59.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 16' ' ' LEU . 2.1 mm? -97.51 -23.69 15.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.313 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 tp . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.201 -179.231 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.461 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.518 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -88.41 -48.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.802 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 80.1 mt -53.41 -44.66 98.0 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.66 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 20.4 Cg_exo -60.05 -37.59 83.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.975 1.784 . . . . 0.0 112.06 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 8' ' ' LEU . 76.4 mt -62.74 -53.9 47.37 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.761 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -34.82 70.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.214 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.51 -47.09 80.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.936 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.9 -43.4 99.38 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.66 12.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.75 -44.99 90.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -26.09 66.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -75.51 -10.97 59.91 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.041 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.4 mt -93.96 -25.8 17.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 tt . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.149 -179.803 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.584 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -81.93 -50.44 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.856 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 68.4 mt -55.33 -50.32 87.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -59.25 -37.15 92.97 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.296 1.331 . . . . 0.0 111.101 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.59 -46.02 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.507 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.96 -38.15 75.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -69.7 -9.81 55.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.705 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.59 -43.8 4.45 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.58 -47.78 39.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.616 ' O ' HG22 ' A' ' 17' ' ' ILE . 26.8 tp -50.95 -42.42 59.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.885 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -67.05 -19.13 65.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.81 0.338 . . . . 0.0 110.441 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -85.91 -21.27 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.524 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.3 mt -96.78 -31.9 12.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.815 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 13' ' ' LEU . 17.8 tt . . . . . 0 C--N 1.322 -0.617 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.487 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -71.93 -43.35 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.293 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.573 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 49.5 mt -68.32 -51.18 25.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.358 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -60.36 -40.47 57.99 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.725 1.617 . . . . 0.0 111.614 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.05 -46.52 82.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.838 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.21 -40.07 95.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.369 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -36.91 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.347 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.97 -46.23 29.55 Favored Glycine 0 N--CA 1.453 -0.22 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.42 -43.58 34.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.6 tp -55.29 -44.75 75.98 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.179 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -59.76 -26.04 65.36 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.775 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -84.83 -7.46 59.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 mt -104.87 -14.2 15.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.651 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 14' ' ' LYS . 5.9 tt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.448 HG12 ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -83.93 -39.11 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.259 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 16.2 mt -77.17 -48.02 2.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.136 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 6.1 Cg_exo -67.24 -31.26 36.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.816 1.677 . . . . 0.0 113.885 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -66.01 -38.66 89.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.692 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.39 -58.8 5.43 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.98 79.91 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -60.07 -52.18 66.47 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 17' ' ' ILE . 50.2 tp -53.03 -43.48 66.6 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.551 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -68.26 -17.28 64.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.639 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -85.02 -7.6 59.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.608 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 111.026 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 13' ' ' LEU . 15.4 tt . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.654 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.497 0.189 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.479 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.1 pt -66.42 -46.06 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.673 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 29.1 mt -77.0 -50.66 2.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.378 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 31.5 Cg_exo -56.06 -41.33 78.02 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.817 1.678 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.93 -44.19 91.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.731 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.21 77.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -35.57 74.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.337 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.92 -38.6 26.48 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -37.89 26.08 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -57.32 -48.12 79.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.79 -28.59 67.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -71.89 -17.46 62.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.763 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.5 tp -101.49 -27.25 13.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.77 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 14' ' ' LYS . 16.4 tt . . . . . 0 C--N 1.322 -0.597 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.125 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -87.18 -42.36 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.205 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.559 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 79.1 mt -58.4 -48.68 96.52 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.004 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 14.3 Cg_endo -66.62 -29.16 44.08 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.838 1.692 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -54.01 39.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.96 66.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.652 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.464 ' O ' ' NZ ' ' A' ' 14' ' ' LYS . 3.0 tp -59.26 -25.37 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.631 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -86.86 -44.93 5.59 Favored Glycine 0 CA--C 1.515 0.079 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.0 -41.43 25.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -56.38 -40.26 74.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.518 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.571 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -68.17 -19.3 64.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.93 -18.52 32.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mp -94.21 -19.86 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.455 -179.859 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.695 ' N ' HG23 ' A' ' 1' ' ' ILE . 10.6 m-85 -46.91 -35.7 6.76 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.004 0.43 . . . . 0.0 111.524 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -73.05 -1.25 55.9 Favored Glycine 0 C--O 1.228 -0.242 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -118.7 -26.49 6.1 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 1' ' ' ILE . 1.1 pt -84.57 -44.82 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.282 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.562 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 84.3 mt -59.19 -49.36 93.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.749 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 12.1 Cg_endo -64.07 -41.5 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.505 1.47 . . . . 0.0 111.211 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.83 -48.45 77.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.858 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -36.0 82.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -58.8 -31.81 68.78 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.362 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -81.25 -47.86 6.27 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.52 -34.18 10.85 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 17' ' ' ILE . 19.6 tp -60.6 -47.22 87.19 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.2 mptp? -61.42 -30.11 70.36 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.476 ' OD1' ' NZ ' ' A' ' 18' ' ' LYS . 30.0 t-20 -76.84 -2.82 35.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.507 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.46 -43.58 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.945 0.403 . . . . 0.0 110.603 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.759 HG23 ' H ' ' A' ' 18' ' ' LYS . 5.1 tt -82.49 -61.19 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.824 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.759 ' H ' HG23 ' A' ' 17' ' ' ILE . 0.7 OUTLIER 63.52 -55.84 0.2 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.208 -178.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . 0.498 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.298 -1.673 0 O-C-N 119.759 -1.838 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.72 HD13 ' N ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.72 ' N ' HD13 ' A' ' 1' ' ' ILE . 12.7 p90 -68.3 -9.7 49.55 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.433 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -72.19 0.1 41.63 Favored Glycine 0 CA--C 1.518 0.242 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.53 -18.1 6.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.475 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 2.5 pt -91.78 -46.69 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.767 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 76.7 mt -73.71 -49.43 6.25 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.741 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 23.9 Cg_exo -63.12 -44.4 15.57 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.058 1.839 . . . . 0.0 112.707 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 8' ' ' LEU . 4.3 mm? -59.61 -48.86 80.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.602 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.86 -25.61 66.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.997 0.427 . . . . 0.0 110.406 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.62 -53.3 35.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.352 0.596 . . . . 0.0 109.547 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.27 -39.55 96.07 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -50.94 -44.95 60.47 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.47 -42.91 74.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.772 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -65.57 -23.78 66.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.738 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 12' ' ' ALA . 41.7 t30 -81.04 -12.69 59.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.059 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.2 mp -101.38 -27.83 12.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.54 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 19' ' ' NH2 . 16.3 tt -94.65 -46.05 13.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.799 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER 60.76 -55.32 0.09 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.035 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . 0.53 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.301 -1.528 0 O-C-N 119.834 -1.791 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.561 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.557 ' H ' HG23 ' A' ' 1' ' ' ILE . 41.1 m-85 -45.73 -28.89 1.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.064 0.459 . . . . 0.0 111.63 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.06 -5.57 41.3 Favored Glycine 0 C--N 1.32 -0.324 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.95 -34.05 3.62 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -78.53 -43.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.387 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 97.6 mt -64.97 -48.19 72.13 Favored Pre-proline 0 C--O 1.222 -0.352 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.944 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 51.5 Cg_exo -46.01 -46.6 15.73 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.13 1.887 . . . . 0.0 112.128 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.91 -44.54 74.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.484 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.45 -35.01 73.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.777 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -62.85 -32.6 73.86 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -83.74 -50.47 4.41 Favored Glycine 0 C--O 1.228 -0.243 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.59 -39.04 22.37 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 tp -55.75 -46.06 77.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.002 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 15.0 mmtm -59.8 -26.38 65.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.055 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.508 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 30.0 t-20 -80.8 -6.42 58.51 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.451 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.46 -32.95 8.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.788 0.328 . . . . 0.0 110.864 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 19' ' ' NH2 . 7.4 tt -90.65 -43.74 14.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.844 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 15' ' ' ASN . 1.1 mptp? 62.77 -53.92 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.516 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . 0.52 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.298 -1.642 0 O-C-N 119.973 -1.704 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.789 HG23 ' H ' ' A' ' 2' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.789 ' H ' HG23 ' A' ' 1' ' ' ILE . 76.8 m-85 -48.41 -29.58 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.093 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 7' ' ' PRO . . . -73.28 -5.51 66.92 Favored Glycine 0 N--CA 1.46 0.235 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.408 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . -110.4 -27.86 8.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.587 ' HA ' HD23 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -85.26 -45.26 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.395 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.486 ' N ' ' CG1' ' A' ' 5' ' ' ILE . 14.1 mt -54.21 -49.24 91.36 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.937 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 27.4 Cg_exo -54.19 -46.31 34.49 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.71 1.607 . . . . 0.0 112.057 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.612 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -62.22 -35.2 78.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.47 ' N ' ' HG ' ' A' ' 8' ' ' LEU . . . -60.63 -41.19 94.39 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -62.92 -38.23 90.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.534 178.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.25 -27.82 65.91 Favored Glycine 0 C--O 1.228 -0.248 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.51 -46.56 88.48 Favored 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 tp -56.64 -41.82 77.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.615 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -58.94 -25.63 63.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.572 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 17.4 t-20 -83.64 -7.47 59.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.791 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 16' ' ' LEU . 2.1 mm? -97.51 -23.69 15.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.313 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.53 HG23 ' N ' ' A' ' 18' ' ' LYS . 4.2 tp -101.74 -46.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.201 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.572 ' NZ ' ' O ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER 57.27 -98.78 0.09 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.203 -179.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.537 0 O-C-N 120.083 -1.636 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 5' ' ' ILE . 8.3 tp . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.498 ' N ' HG13 ' A' ' 1' ' ' ILE . 70.9 m-85 -39.65 -37.6 0.53 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.185 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.72 -8.26 39.46 Favored Glycine 0 N--CA 1.461 0.301 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.461 ' C ' ' HD2' ' A' ' 7' ' ' PRO . . . -116.63 -26.39 7.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.012 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 1' ' ' ILE . 0.1 OUTLIER -88.41 -48.29 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.802 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.543 ' N ' ' CD ' ' A' ' 7' ' ' PRO . 80.1 mt -53.41 -44.66 98.0 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.66 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 6' ' ' LEU . 20.4 Cg_exo -60.05 -37.59 83.48 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.975 1.784 . . . . 0.0 112.06 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 8' ' ' LEU . 76.4 mt -62.74 -53.9 47.37 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.115 0.483 . . . . 0.0 109.761 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -34.82 70.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.214 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.51 -47.09 80.19 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.936 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.9 -43.4 99.38 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.66 12.49 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.6 tp -58.75 -44.99 90.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -26.09 66.04 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.568 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 6.6 t-20 -75.51 -10.97 59.91 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.041 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.469 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 65.4 mt -93.96 -25.8 17.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.692 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 18' ' ' LYS . 8.9 tt -93.82 -43.36 13.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.149 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' NZ ' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 52.81 -130.73 2.2 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.5 0 O-C-N 119.943 -1.723 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.673 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.584 ' H ' HG23 ' A' ' 1' ' ' ILE . 8.1 m-85 -49.96 -34.66 21.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.505 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 7' ' ' PRO . . . -72.81 3.67 26.25 Favored Glycine 0 C--N 1.323 -0.188 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -120.44 -29.96 4.66 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 1' ' ' ILE . 1.1 pt -81.93 -50.44 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.856 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.598 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 68.4 mt -55.33 -50.32 87.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.648 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -59.25 -37.15 92.97 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.296 1.331 . . . . 0.0 111.101 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.59 -46.02 91.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.507 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.96 -38.15 75.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 10' ' ' LEU . 1.0 OUTLIER -69.7 -9.81 55.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.705 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.59 -43.8 4.45 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.58 -47.78 39.42 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.616 ' O ' HG22 ' A' ' 17' ' ' ILE . 26.8 tp -50.95 -42.42 59.82 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.885 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -67.05 -19.13 65.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.81 0.338 . . . . 0.0 110.441 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -85.91 -21.27 28.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.524 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 23.3 mt -96.78 -31.9 12.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.815 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 13' ' ' LEU . 17.8 tt -95.59 -41.82 12.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.2 OUTLIER 63.26 -127.1 0.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.867 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.466 0 O-C-N 119.596 -1.94 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.727 HG23 ' H ' ' A' ' 3' ' ' GLY . 5.1 tp . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.564 ' H ' HG13 ' A' ' 1' ' ' ILE . 0.1 OUTLIER -48.18 -25.19 1.39 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.243 0.544 . . . . 0.0 110.558 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.727 ' H ' HG23 ' A' ' 1' ' ' ILE . . . -72.69 6.51 11.95 Favored Glycine 0 CA--C 1.518 0.223 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 1' ' ' ILE . . . -127.04 -38.24 2.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -71.93 -43.35 68.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.293 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.573 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 49.5 mt -68.32 -51.18 25.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.358 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 9.5 Cg_endo -60.36 -40.47 57.99 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.725 1.617 . . . . 0.0 111.614 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.05 -46.52 82.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.838 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.21 -40.07 95.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.369 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.12 -36.91 71.23 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.347 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.97 -46.23 29.55 Favored Glycine 0 N--CA 1.453 -0.22 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.42 -43.58 34.3 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.6 tp -55.29 -44.75 75.98 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.179 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -59.76 -26.04 65.36 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.775 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -84.83 -7.46 59.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.5 mt -104.87 -14.2 15.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.651 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 18' ' ' LYS . 5.9 tt -102.75 -43.46 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' N ' HG23 ' A' ' 17' ' ' ILE . 4.7 mmtm 65.88 -51.68 0.39 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.426 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . 0.425 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.552 0 O-C-N 120.172 -1.58 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.558 ' CG1' ' H ' ' A' ' 2' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.558 ' H ' ' CG1' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -52.17 -20.25 2.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.791 0.329 . . . . 0.0 110.845 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.529 ' H ' HG23 ' A' ' 1' ' ' ILE . . . -72.89 3.0 30.33 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.21 -30.99 3.38 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 2' ' ' PHE . 0.8 OUTLIER -83.93 -39.11 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.259 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 16.2 mt -77.17 -48.02 2.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.571 -0.452 . . . . 0.0 112.136 -178.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 6.1 Cg_exo -67.24 -31.26 36.08 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.816 1.677 . . . . 0.0 113.885 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -66.01 -38.66 89.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.692 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' N ' HD12 ' A' ' 8' ' ' LEU . . . -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.39 -58.8 5.43 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.68 -31.98 79.91 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -60.07 -52.18 66.47 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 17' ' ' ILE . 50.2 tp -53.03 -43.48 66.6 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.551 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -68.26 -17.28 64.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.269 -0.573 . . . . 0.0 110.639 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -85.02 -7.6 59.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.608 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -112.08 -46.44 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.215 0.531 . . . . 0.0 111.026 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 18' ' ' LYS . 15.4 tt -88.04 -45.63 15.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.654 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER 66.89 -150.63 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.808 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.59 0 O-C-N 119.902 -1.748 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 5' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.63 ' H ' HG23 ' A' ' 1' ' ' ILE . 0.1 OUTLIER -65.36 -2.92 3.53 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.229 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.04 1.07 81.41 Favored Glycine 0 C--N 1.322 -0.228 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.61 -35.21 0.74 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.067 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 1' ' ' ILE . 1.1 pt -66.42 -46.06 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.673 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . 29.1 mt -77.0 -50.66 2.24 Favored Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.378 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.568 ' HD3' ' HB2' ' A' ' 6' ' ' LEU . 31.5 Cg_exo -56.06 -41.33 78.02 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.817 1.678 . . . . 0.0 111.598 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -58.93 -44.19 91.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.731 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.21 77.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.449 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -35.57 74.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.337 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.92 -38.6 26.48 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -37.89 26.08 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -57.32 -48.12 79.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HA ' HG22 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -59.79 -28.59 67.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' O ' ' NZ ' ' A' ' 18' ' ' LYS . 53.5 t30 -71.89 -17.46 62.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.763 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.467 ' C ' ' HD2' ' A' ' 18' ' ' LYS . 5.5 tp -101.49 -27.25 13.23 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.77 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 14' ' ' LYS . 16.4 tt -84.92 -44.15 17.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.125 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.48 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.1 OUTLIER 50.33 35.71 11.36 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.756 0.312 . . . . 0.0 110.424 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.566 0 O-C-N 119.885 -1.759 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.61 HG23 ' H ' ' A' ' 3' ' ' GLY . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.535 ' H ' ' CG1' ' A' ' 1' ' ' ILE . 1.0 OUTLIER -45.66 -30.5 1.56 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.085 0.469 . . . . 0.0 111.322 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.61 ' H ' HG23 ' A' ' 1' ' ' ILE . . . -67.53 -7.74 48.37 Favored Glycine 0 N--CA 1.459 0.215 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.61 -29.8 7.03 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 1' ' ' ILE . 0.2 OUTLIER -87.18 -42.36 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.205 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.559 ' N ' ' HD2' ' A' ' 7' ' ' PRO . 79.1 mt -58.4 -48.68 96.52 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.004 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 6' ' ' LEU . 14.3 Cg_endo -66.62 -29.16 44.08 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 121.838 1.692 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -54.01 39.0 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.03 -34.96 66.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.652 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' O ' ' NZ ' ' A' ' 14' ' ' LYS . 3.0 tp -59.26 -25.37 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.631 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 14' ' ' LYS . . . -86.86 -44.93 5.59 Favored Glycine 0 CA--C 1.515 0.079 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.0 -41.43 25.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -56.38 -40.26 74.3 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.518 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -68.17 -19.3 64.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.93 -18.52 32.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.854 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.458 ' C ' ' HD3' ' A' ' 18' ' ' LYS . 4.3 mp -94.21 -19.86 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.895 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 18' ' ' LYS . 4.4 tt -85.42 -48.84 16.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.455 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER 65.18 -52.75 0.34 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.47 179.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' NH2 . . . . . 0.463 ' N ' ' O ' ' A' ' 17' ' ' ILE . . . . . . . . 0 C--N 1.3 -1.58 0 O-C-N 120.174 -1.579 . . . . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_